Simon Jackson

5.3k total citations
47 papers, 4.1k citations indexed

About

Simon Jackson is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Simon Jackson has authored 47 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 14 papers in Surgery and 9 papers in Oncology. Recurrent topics in Simon Jackson's work include Cholesterol and Lipid Metabolism (8 papers), Peroxisome Proliferator-Activated Receptors (6 papers) and Lipoproteins and Cardiovascular Health (5 papers). Simon Jackson is often cited by papers focused on Cholesterol and Lipid Metabolism (8 papers), Peroxisome Proliferator-Activated Receptors (6 papers) and Lipoproteins and Cardiovascular Health (5 papers). Simon Jackson collaborates with scholars based in United States, United Kingdom and Canada. Simon Jackson's co-authors include Linda L. Demer, Peter A. Edwards, Johan Ericsson, Willa A. Hsueh, Ronald E. Law, Kenneth R. Feingold, Peter M. Elias, Farhad Parhami, Xiao-Ping Xi and Woerner P. Meehan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Simon Jackson

45 papers receiving 4.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simon Jackson United States 28 2.1k 1.2k 547 462 450 47 4.1k
Alane Koki United States 25 1.6k 0.7× 541 0.5× 1.1k 1.9× 126 0.3× 332 0.7× 38 6.2k
Zemin Yao Canada 45 2.6k 1.2× 1.7k 1.4× 856 1.6× 100 0.2× 921 2.0× 115 6.7k
Yasuo Ishida Japan 25 900 0.4× 817 0.7× 380 0.7× 165 0.4× 436 1.0× 112 3.0k
Pierre Formstecher France 35 2.4k 1.1× 325 0.3× 344 0.6× 123 0.3× 459 1.0× 114 3.9k
Kiyoshi Nose Japan 38 3.0k 1.4× 379 0.3× 641 1.2× 70 0.2× 526 1.2× 121 4.5k
William P. Bennett United States 35 2.5k 1.2× 494 0.4× 1.3k 2.3× 100 0.2× 312 0.7× 62 5.0k
H Hiai Japan 25 1.7k 0.8× 419 0.4× 309 0.6× 60 0.1× 515 1.1× 47 3.4k
Andrea S. Bauer Germany 33 1.7k 0.8× 326 0.3× 484 0.9× 119 0.3× 381 0.8× 99 3.1k
In Gyu Kim South Korea 34 1.3k 0.6× 207 0.2× 299 0.5× 178 0.4× 286 0.6× 124 3.1k
Hidetoshi Hayashi Japan 30 3.2k 1.5× 384 0.3× 572 1.0× 45 0.1× 805 1.8× 131 5.2k

Countries citing papers authored by Simon Jackson

Since Specialization
Citations

This map shows the geographic impact of Simon Jackson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Jackson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Jackson more than expected).

Fields of papers citing papers by Simon Jackson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon Jackson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Jackson. The network helps show where Simon Jackson may publish in the future.

Co-authorship network of co-authors of Simon Jackson

This figure shows the co-authorship network connecting the top 25 collaborators of Simon Jackson. A scholar is included among the top collaborators of Simon Jackson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon Jackson. Simon Jackson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
LaGory, Edward L., Jamila Gupte, Yan Gong, et al.. (2024). Liver-specific mitochondrial amidoxime–reducing component 1 (Mtarc1) knockdown protects the liver from diet-induced MASH in multiple mouse models. Hepatology Communications. 8(5). 4 indexed citations
3.
Cheng, Paul, Chad S. Weldy, Ramendra Kundu, et al.. (2023). Molecular mechanisms of coronary artery disease risk at the PDGFD locus. Nature Communications. 14(1). 847–847. 14 indexed citations
4.
Lebeau, Paul, Hanny Wassef, Jae Hyun Byun, et al.. (2020). The loss-of-function PCSK9Q152H variant increases ER chaperones GRP78 and GRP94 and protects against liver injury. Journal of Clinical Investigation. 131(2). 30 indexed citations
5.
Raal, Frederick J., Robert P. Giugliano, Marc S. Sabatine, et al.. (2016). REDUCTION IN LIPOPROTEIN (A) WITH EVOLOCUMAB: ELUCIDATION OF THE ROLE OF THE LDL RECEPTOR FROM CLINICAL TRIALS AND IN-VITRO MODELS. Journal of the American College of Cardiology. 67(13). 1862–1862. 1 indexed citations
6.
Henne, Kirk R., Brandon Ason, Monique Howard, et al.. (2015). Anti-PCSK9 Antibody Pharmacokinetics and Low-Density Lipoprotein-Cholesterol Pharmacodynamics in Nonhuman Primates Are Antigen Affinity–Dependent and Exhibit Limited Sensitivity to Neonatal Fc Receptor–Binding Enhancement. Journal of Pharmacology and Experimental Therapeutics. 353(1). 119–131. 20 indexed citations
7.
Xu, Ren, Clapton Dias, Bing Gao, et al.. (2014). EFFECTS OF EVOLOCUMAB ON LIPOPROTEIN PARTICLES AND SUBCLASSES IN HYPERCHOLESTEROLEMIC AND HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA SUBJECTS ON STATIN THERAPY. Journal of the American College of Cardiology. 63(12). A1378–A1378. 2 indexed citations
8.
Ason, Brandon, José W.A. van der Hoorn, Joyce Chan, et al.. (2014). PCSK9 inhibition fails to alter hepatic LDLR, circulating cholesterol, and atherosclerosis in the absence of ApoE. Journal of Lipid Research. 55(11). 2370–2379. 61 indexed citations
9.
Fox, Brian M., Kiyosei Iio, Kexue Li, et al.. (2010). Discovery of pyrrolopyridazines as novel DGAT1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(20). 6030–6033. 23 indexed citations
10.
Jackson, Simon, et al.. (2010). One year impact of a single dose of Praziquantel in five schistosomiasis endemic districts in Rwanda. International Journal of Infectious Diseases. 14. e332–e332. 1 indexed citations
11.
Xu, Jinsheng & Simon Jackson. (2009). Current Considerations for the Effective Safety Evaluation of Drugs In Vitro. Mini-Reviews in Medicinal Chemistry. 9(7). 861–868. 2 indexed citations
12.
Piper, Derek E., Simon Jackson, Qiang Liu, et al.. (2007). The Crystal Structure of PCSK9: A Regulator of Plasma LDL-Cholesterol. Structure. 15(5). 545–552. 204 indexed citations
13.
Jackson, Simon & Linda L. Demer. (2000). Peroxisome proliferator‐activated receptor activators modulate the osteoblastic maturation of MC3T3‐E1 preosteoblasts. FEBS Letters. 471(1). 119–124. 79 indexed citations
14.
Tintut, Yin, Farhad Parhami, Kristina I. Boström, Simon Jackson, & Linda L. Demer. (1998). cAMP Stimulates Osteoblast-like Differentiation of Calcifying Vascular Cells. Journal of Biological Chemistry. 273(13). 7547–7553. 153 indexed citations
15.
Jackson, Simon & J.B. Cooper. (1998). An analysis of structural similarity in the iron and manganese superoxide dismutases based on known structures and sequences. BioMetals. 11(2). 159–173. 47 indexed citations
16.
Ericsson, Johan, Simon Jackson, Jae Bum Kim, Bruce M. Spiegelman, & Peter A. Edwards. (1997). Identification of Glycerol-3-phosphate Acyltransferase as an Adipocyte Determination and Differentiation Factor 1- and Sterol Regulatory Element-binding Protein-responsive Gene. Journal of Biological Chemistry. 272(11). 7298–7305. 210 indexed citations
17.
Ericsson, Johan, Simon Jackson, & Peter A. Edwards. (1996). Synergistic Binding of Sterol Regulatory Element-binding Protein and NF-Y to the Farnesyl Diphosphate Synthase Promoter Is Critical for Sterol-regulated Expression of the Gene. Journal of Biological Chemistry. 271(40). 24359–24364. 96 indexed citations
18.
Jackson, Simon, Johan Ericsson, Timothy F. Osborne, & Peter A. Edwards. (1995). NF-Y Has a Novel Role in Sterol-dependent Transcription of Two Cholesterogenic Genes. Journal of Biological Chemistry. 270(37). 21445–21448. 104 indexed citations
19.
Jackson, Simon, Mao‐Qiang Man, Peter M. Elias, & Kenneth R. Feingold. (1994). Role of Exogenous Oxygen in Cutaneous Barrier Repair. Skin Pharmacology and Physiology. 7(6). 316–319. 1 indexed citations
20.
Wood, Ladonna C., Simon Jackson, Peter M. Elias, Carl Grünfeld, & Kenneth R. Feingold. (1992). Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice.. Journal of Clinical Investigation. 90(2). 482–487. 353 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alane Koki Breakdown of academic impact, for papers by Zemin Yao Breakdown of academic impact, for papers by Yasuo Ishida Breakdown of academic impact, for papers by Pierre Formstecher Breakdown of academic impact, for papers by Kiyoshi Nose Breakdown of academic impact, for papers by William P. Bennett Breakdown of academic impact, for papers by H Hiai Breakdown of academic impact, for papers by Andrea S. Bauer Breakdown of academic impact, for papers by In Gyu Kim Breakdown of academic impact, for papers by Hidetoshi Hayashi
Rankless by CCL
2026